EX-23.1 3 ex23-1.htm

 

EXHIBIT 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-229432) and Form S-3 (File No. 333-251988) of AgeX Therapeutics, Inc. of our report dated March 31, 2021, relating to the consolidated financial statements of AgeX Therapeutics, Inc., which appears in this Annual Report on Form 10-K.

 

/s/ OUM & Co. LLP  
   
San Francisco, California  
March 31, 2021